Dissolution enhancement of drugs part II: Effect of carriers

International Journal of Health Research

Volumn 2, Issue 3, 2009, Pages 207-223

  Saharan, Vikas A ^a   Kukkar, Vipin ^a   Kataria, Mahesh ^a   Gera, Manoj ^a   Choudhury, Pratim K ^b  

^a Institute of Pharmaceutical Sciences and Drug Research   (India)

^b M L SUKHADIA UNIVERSITY   (India)

Author keywords

Aqueous solubility, water soluble carriers; Dissolution enhancement; Lipophilic, excipients

Indexed keywords

ACYLGLYCEROL; CARBAMAZEPINE; CARBOHYDRATE; CELECOXIB; CYCLODEXTRIN; DANAZOL; DENDRIMER; DIAZEPAM; DISINTEGRATING AGENT; DRUG CARRIER; FENTANYL; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; GRISEOFULVIN; HYDROTROPE; INDOMETACIN; MELOXICAM; NAPROXEN; NICARDIPINE; NIFEDIPINE; NIMESULIDE; NORFLOXACIN; PIROXICAM; POLYMER; ROFECOXIB; SATRANIDAZOLE; SURFACTANT; UNINDEXED DRUG; ZIPRASIDONE;

DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; HIGH THROUGHPUT SCREENING; LIPOPHILICITY; REVIEW;

EID: 77953424546     PISSN: None     EISSN: 15969819     Source Type: Journal    
DOI: 10.4314/ijhr.v2i3.47904     Document Type: Review

References (56)

1. Kasim N, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain A, Junginger H, Stavchansky S, Midha K, Shah V, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharmaceut. 2004;1:85-96.
2. Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu L, Amidon G. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol. Pharmaceut. 2006;3:631-643.
3. Waiver of in vivo bioavailability and bioequivalence studies for Immediate-release solid oral dosage forms based on a biopharmaceutics classification system, 2002. FDA Guidance for Industry; Federal Drug and Food Administration: Rockville, MD, 2002.
4. Varma M, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A, Sood A, Thomas N, Pillai O, Sharma P, Gandhi R, et al. Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Curr. Drug Metab. 2004;5:375-388.
5. Wadetwar R, Upadhye K, Bakhle S, Deshpande S, Nagulwar V. Production of beta-Cyclodextrin: Effect of pH, time and additives. Indian J Pharm Sci 2006;520-523.
6. Chowdary KPR. Cyclodextrins as drug carriers. Indian Pharmacist 2003;II:11-14.
7. Parikh RK, Mansuri NS, Gohel MC, Sonlwala MM. Dissolution enhancement of nimesulide using complexation and salt formation techniques. Indian Drugs 2005;42:149-153.
8. Sinco TJ. Complexation and protein binding. In: Martin A, Martin As. Martin's physical pharmacy and pharmaceutical sciences. V. New delhi: Wolters Kluwer Health (india) Pvt ltd; 2007. 277 p.
9. Blanchard J, S P. Some important considerations in the use of cyclodextrins. Pharm Res 1999;16:1796-1798.
10. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Physicochemical characterization and dissolution of norfloxacin / cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 1995;123:53-63.
11. Moyano JR, Blanco MJA, Gines JM, Giordano F. Solid-state characterization and dissolution characteristics of gliclazide-beta-cyclodextrin inclusion complexes. Int J Pharm 1997;148:211-217.
12. El-Zein H, Riad L, El-Bary AA. Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation. Int J Pharm 1998;168:209-220.
13. Ozkan Y, Atay T, Dikmen N, Isimer A, Hassan Y, Enein A. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin. Pharm Acta Helv 2000;74:365-370.
14. Rogers TL, Nelsen AC, J H, N BJ. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm 2002;54:271-280.
15. Fernandes CM, Vieira MT, Veiga FJB. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci 2002;15:79-88.
16. Baboota S, Agarwal SP. Formulation of meloxicam cyclodextrin inclusion complexes incorporated tablets. Indian Pharmacist May 2005;IV:62-66.
17. Aithal KS, Nalini K, Udupa N, Sreenivasan KK. Enhanced fluorescence emission of norfloxacin on complexation with cyclodextrin. Indian Drugs 2005;42:162-166.
18. Jug M. Influence of cyclodextrin complexation on piroxicam gel formulations. Acta Pharm 2005;55:223-236.
19. Rawat S, Asgar LF, Jain SK. A comparative dissolution study of commercial and prepared formulations of celecoxib. Indian J Pharm Sci 2005;632-634.
20. Derle D, Boddu SHS, Magar M. Studies on the preparation, characterization and solubility of betacyclodextrin - satranidazole inclusion complexes. Indian J Pharm Educ Res 2006;40:232-236.
21. Suresh S, Shivakumar HN, Kumar GK. Effect of beta cyclodextrin complexation on the solubility and dissolution rate of carbamazepine from tablets. Indian J Pharm Sci 2006;301-307.
22. Zerrouk N, Corti G, Ancillotti S, Maestrelli F, Cirri M, Mura P. Influence of Cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Eur J Pharm Biopharm 2006;62:241-246.
23. Lo YK, Hsu CP, Tsai TR, Cham TM. Comparison of the solubility and dissolution rate of gliclazide-betacyclodextrin inclusion complexes prepared by liquid-liquid extraction and neutralization. J Food Drug Ana 2006;14:230-235.
24. Deshmukh SS, Potnis VV, Shelar DB, Mahaparale PR. Studies on inclusion complexes of ziprasidone hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Indian Drugs 2007;44:677-682.
25. Doijad RC, Kanakal MM, Manvi FV. Studies on piroxicam beta-cyclodextrin inclusion complexes. Indian Pharmacist Jan 2007;VI:94-98.
26. Patel VP, Patel NM, Chaudhari BG. Effect of water soluble polymers on dissolution profile of glipizide Cyclodextrins complex. Indian Drugs 2008;45:31-36.
27. Cavallari C, Abertini B, Rodriguez MLG, L R. Improved dissolution behaviour of steam-granulated piroxicam. Eur J Pharm Biopharm 2002;54:65-73.
28. Bettinetti G, Mura P. Dissolution properties of naproxen in combination with polyvinylpyrrolidone. Drug Dev Ind Pharm 1994;20:1353-1366.
29. Sugimoto M, Okagaki T, Narisawa S, Koida Y, Nakajima K. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drug by novel cogrinding method using water-soluble polymer. Int J Pharm 1998;160:11-19.
30. Alway B, Sangchantra R, Stewart PJ. Modelling the dissolution of diazepam in lactose interactive mixtures. Int J Pharm 1996;130:213-224.
31. Bredenberg SS, Lennegnas B. Invitro and invivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance. Eur J Pharm Sci 2003;20:327-334.
32. Allahham A, Stewart P. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose. Eur J Pharm Biopharm 2007;67:732-742.
33. Portero A, Lopez R, Jato JLV. Effect of chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine. Int J Pharm 1998;175:75-84.
34. Saito M, Ugajin T, Nozawa Y, Sadzuka Y, Miagishima A, T S. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides. Int J Pharm 2002;249:71-79.
35. Zajc N, Obreza A, Bele M, Srcic S. Physical properties and dissolution behavior of nifedipine/mannitol solid dispersions prepared by hot melt method. Int J Pharm 2005;291:51-58.
36. Ahuja N, Katare OP, B S. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007;65:26-38.
37. Nystrom C, Westerberg M. The use of ordered mixtures for improving the dissolution rate of low solubility compounds. J Pharm Pharmacol 1986;38:161-165.
38. Rathore KS, Tanwar YS, Gupta GD. Solubility enhancement and formulation of nimesulide injection using hydrotropes. Pharma Review Dec. 2006;171-176.
39. Maheshwari RK. Application of hydrotropic solubilization phenomenon in spectrophotometric estimation of norfloxacin in tablets. Indian J Pharm Educ Res 2006;40.
40. Maheshwari RK. Solid dispersion and syrup formulation of poorly water soluble drug by hydrotropy. Indian Pharmacist Aug. 2006;V:87-90.
41. Maheshwari RK. A novel application of hydrotropic solubilization in the spectrophotometric estimation of frusemide in tablets. Pharma Review Oct. 2006;148-150.
42. Maheshwari RK, Tewari A. Spectrophotometric estimation of drugs using hydrotropic solubilization phenomenon. Indian Pharmacist 2005;IV:79-84.
43. Tashtoush BM, Al-Qashi ZS, Najib NM. Invitro and invivo evaluation of glibenclamide in solid dispersion systems. Drug Dev Ind Pharm 2004;30:601-607.
44. Karatas A, Nilufer Y, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. IL Farmaco 2005;60:777-782.
45. Chauhan B, Shimpi S, Paradkar A. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur J Pharm Sci 2005;26:219-230.
46. Milhem OM, Myles C, McKeown NB, Attwood D, AD. E. Polyamidoamine Starburst® dendrimers as solubility enhancers. Int J Pharm 2000;197:239-241.
47. D'Emanuele A, Attwood D. Dendrimer-drug interactions. Adv Drug Deliv Rev 2005;57:2147-2162.
48. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005;57: 2106-2129.
49. Stella VJ, Addae KWN. Prodrug strategies to overcome poor water solubility. Adv Drug Deliv Rev 2007;59: 677-694.
50. Jaiswal SB, Brahmankar DM. Biopharmaceutics and pharmacokinetics: a treatise. Delhi: Vallabh Prakashan; 1999. 25, 165 p.
51. Jalali MB, Maleki N, Garjani A, Khandar AA. Enhancement of dissolution rate and ante-inflammatory effects of piroxicam using solvent deposition technique. Drug Dev Ind Pharm 2002;28:681-686.
52. Alsidan S, Malsughayer AA, Eshra AG. Improved dissolution rate of indomethacin by adsorbents. Drug Dev Ind Pharm 1998;24:389-394.
53. Ganesan V, Sivakumar SM, Kannadasan M. Enhancement of dissolution rate of flurbiprofen. Indian Pharmacist 2004;III:61-64.
54. Spence JK, Bhattachar SN, Wesley JA, Martin PJ, Babu SR. Increased dissolution rate and bioavailability through comicronization with microcrystalline cellulose. Drug Dev Ind Pharm 2005;10:451-460.
55. Varma MM, Pandit JK. Influence of urea and xylitol on the dissolution rate of flurbiprofen. Indian Pharmacist 2005;97-99.
56. Mishra DN, Kumar SGV. Investigations on analgesic, anti-inflammatory and ulcerogenic potential of meloxicam solid dispersion prepared with skimmed milk. Yakugaku Zasshi 2006;126:495-498.